Unfractionated Heparin Safety in COVID-19: Incidence and Risks of Bleeding Complications in Japan.

Lubna SatoNoriko IwamotoYuko KakumotoShinya TsuzukiTomiteru ToganoMasahiro IshikaneNobumasa OkumuraGen YamadaMakoto InadaTetsuya SuzukiMasayuki HojoJin TakasakiRyo SasakiAkio KimuraKatsuji TeruyaTatsuya OkamotoKayoko HayakawaHisao HaraKen IsekiNorio Ohmagari

Published in: Journal of atherosclerosis and thrombosis (2024)

The incidence of major bleeding in COVID-19 patients using therapeutic-dose UFH was relatively high. Critical COVID-19 and older age were risk factors for bleeding complications.

Keyphrases

sars cov
risk factors
coronavirus disease
atrial fibrillation
middle aged
human health
growth factor
community dwelling
risk assessment